BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. Surgery. 2017;162:500-514. [PMID: 28551378 DOI: 10.1016/j.surg.2017.03.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Naito Y, Kawahara A, Okabe Y, Ishida Y, Sadashima E, Murata K, Takase Y, Abe H, Yamaguchi T, Tanigawa M, Mihara Y, Kondo R, Kusano H, Nakayama M, Shimamatsu K, Yano H, Akiba J. SurePath® LBC improves the diagnostic accuracy of intrahepatic and hilar cholangiocarcinoma. Cytopathology 2018;29:349-54. [PMID: 29723910 DOI: 10.1111/cyt.12565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Franken LC, Schreuder AM, Roos E, van Dieren S, Busch OR, Besselink MG, van Gulik TM. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis. Surgery. 2019;165:918-928. [PMID: 30871811 DOI: 10.1016/j.surg.2019.01.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
3 Yamada M, Mizuno T, Yamaguchi J, Yokoyama Y, Igami T, Onoe S, Watanabe N, Uehara K, Matsuo K, Ebata T. Superiority of clinical American Joint Committee on Cancer T classification for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2021. [PMID: 34717042 DOI: 10.1002/jhbp.1066] [Reference Citation Analysis]
4 Ruzzenente A, Bagante F, Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Koerkamp BG, Jarnagin WR, Nadalin S, Pratschke J, Schmelzle M, Sparrelid E, Lang H, Iacono C, van Gulik TM, Guglielmi A; Perihilar Cholangiocarcinoma Collaboration Group. Surgery for Bismuth-Corlette Type 4 Perihilar Cholangiocarcinoma: Results from a Western Multicenter Collaborative Group. Ann Surg Oncol 2021. [PMID: 33956275 DOI: 10.1245/s10434-021-09905-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Hosokawa I, Furukawa K, Takayashiki T, Kuboki S, Takano S, Miyazaki M, Ohtsuka M. Surgical implications of the confluence patterns of the left intrahepatic bile ducts in right hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2021. [PMID: 34498387 DOI: 10.1002/jhbp.1044] [Reference Citation Analysis]
6 Ishida T, Nara S, Akahoshi K, Takamoto T, Kishi Y, Esaki M, Hiraoka N, Shimada K. Left hepatic trisectionectomy for perihilar cholangiocarcinoma with a right-sided round ligament: A case report. World J Gastrointest Surg 2020; 12(2): 68-76 [PMID: 32128030 DOI: 10.4240/wjgs.v12.i2.68] [Reference Citation Analysis]
7 Wronka KM, Grąt M, Stypułkowski J, Bik E, Patkowski W, Krawczyk M, Zieniewicz K. Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma. J Clin Med 2019;8:E458. [PMID: 30959757 DOI: 10.3390/jcm8040458] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ebata T, Mizuno T, Yokoyama Y, Igami T, Yamaguchi J, Onoe S, Watanabe N, Nagino M. Predictive performance of Blumgart T staging for perihilar cholangiocarcinoma in a Japanese center. J Hepatobiliary Pancreat Sci 2020;27:132-40. [PMID: 31654600 DOI: 10.1002/jhbp.694] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Tang Z, Yang Y, Zhao Z, Wei K, Meng W, Li X. The clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e11999. [PMID: 30142840 DOI: 10.1097/MD.0000000000011999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
10 Kovalenko YA, Zharikov YO, Konchina NA, Gurmikov BN, Marinova LA, Zhao AV. Perihilar cholangiocarcinoma: A different concept for radical resection. Surg Oncol 2020;33:270-5. [PMID: 32561092 DOI: 10.1016/j.suronc.2020.02.013] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ruzzenente A, Bagante F, Ardito F, Campagnaro T, Scoleri I, Conci S, Iacono C, Giuliante F, Guglielmi A. Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma. Surgery. 2018;164:244-250. [PMID: 29801730 DOI: 10.1016/j.surg.2018.03.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
12 Jansson H, Olthof PB, Bergquist A, Ligthart MAP, Nadalin S, Troisi RI, Groot Koerkamp B, Alikhanov R, Lang H, Guglielmi A, Cescon M, Jarnagin WR, Aldrighetti L, van Gulik TM, Sparrelid E; Perihilar Cholangiocarcinoma Collaboration Group. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study. HPB (Oxford) 2021:S1365-182X(21)00111-8. [PMID: 33975797 DOI: 10.1016/j.hpb.2021.04.011] [Reference Citation Analysis]
13 Lu J, Li B, Li FY, Ye H, Xiong XZ, Cheng NS. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated? Eur J Surg Oncol 2019;45:2173-9. [PMID: 31208772 DOI: 10.1016/j.ejso.2019.06.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Olthof PB, Miyasaka M, Koerkamp BG, Wiggers JK, Jarnagin WR, Noji T, Hirano S, van Gulik TM. A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers. HPB (Oxford). 2019;21:345-351. [PMID: 30087051 DOI: 10.1016/j.hpb.2018.07.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
15 Zhao J, Zhang W, Zhang J, Chen YT, Ma WJ, Liu SY, Li FY, Song B. Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup. Cancer Manag Res 2020;12:13111-23. [PMID: 33376403 DOI: 10.2147/CMAR.S289094] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chu KK, Wong KH, Chok KS. Expanding Indications for Liver Transplant: Tumor and Patient Factors. Gut Liver 2021;15:19-30. [PMID: 32102130 DOI: 10.5009/gnl19265] [Reference Citation Analysis]
17 Fisher AV, Ronnekleiv-kelly SM. Surgical Management of Hilar Cholangiocarcinoma. Curr Surg Rep 2018;6. [DOI: 10.1007/s40137-018-0210-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Blaga MM, Brasoveanu V, Stroescu C, Ionescu M, Popescu I, Dumitrascu T. Pattern of the First Recurrence Has No Impact on Long-Term Survival after Curative Intent Surgery for Perihilar Cholangiocarcinomas. Gastroenterol Res Pract 2018;2018:2546257. [PMID: 30158963 DOI: 10.1155/2018/2546257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Geers J, Jaekers J, Topal H, Aerts R, Vandoren C, Vanden Boer G, Topal B. Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma. World J Surg Oncol 2020;18:286. [PMID: 33143698 DOI: 10.1186/s12957-020-02060-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Hau HM, Meyer F, Jahn N, Rademacher S, Sucher R, Seehofer D. Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma. J Clin Med 2020;9:E3152. [PMID: 33003424 DOI: 10.3390/jcm9103152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Franken LC, Rassam F, van Lienden KP, Bennink RJ, Besselink MG, Busch OR, Erdmann JI, van Gulik TM, Olthof PB. Effect of structured use of preoperative portal vein embolization on outcomes after liver resection of perihilar cholangiocarcinoma. BJS Open 2020;4:449-55. [PMID: 32181590 DOI: 10.1002/bjs5.50273] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Malik AK, Robinson SM, French JJ, Sen G, Wilson CH, Hammond JS, White SA, Manas DM. Surgery for Hilar cholangiocarcinoma: the Newcastle upon Tyne Liver Unit experience. Eur Surg 2019;51:197-205. [DOI: 10.1007/s10353-019-0599-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Mehrabi A, Khajeh E, Ghamarnejad O, Nikdad M, Chang D, Büchler MW, Hoffmann K. Meta-analysis of the efficacy of preoperative biliary drainage in patients undergoing liver resection for perihilar cholangiocarcinoma. European Journal of Radiology 2020;125:108897. [DOI: 10.1016/j.ejrad.2020.108897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Quinn LM, Dunne DFJ, Jones RP, Poston GJ, Malik HZ, Fenwick SW. Optimal perioperative care in peri-hilar cholangiocarcinoma resection. Eur Surg 2018;50:93-9. [PMID: 29875797 DOI: 10.1007/s10353-018-0529-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Ji GW, Zhang YD, Wang K, Zhang H, Shao ZC, Jiang WJ, Li XC, Wang XH. Short- and long-term outcomes of middle hepatic vein-oriented hepatectomy for advanced perihilar cholangiocarcinoma. J Surg Oncol 2018;118:446-54. [PMID: 30098303 DOI: 10.1002/jso.25181] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Chen KJ, Yang FC, Qin YS, Jin J, Zheng SS. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 2018;17:155-162. [PMID: 29636302 DOI: 10.1016/j.hbpd.2018.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Goldaracena N, Gorgen A, Sapisochin G. Current status of liver transplantation for cholangiocarcinoma. Liver Transpl. 2018;24:294-303. [PMID: 29024405 DOI: 10.1002/lt.24955] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
28 Moghe A, Ganesh S, Humar A, Molinari M, Jonassaint N. Expanding Donor Selection and Recipient Indications for Living Donor Liver Transplantation. Clin Liver Dis 2021;25:121-35. [PMID: 33978574 DOI: 10.1016/j.cld.2020.08.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Giuliante F, Ardito F, Aldrighetti L, Ferrero A, Pinna AD, De Carlis L, Cillo U, Jovine E, Portolani N, Gruttadauria S, Mazzaferro V, Massani M, Rosso E, Ettorre GM, Ratti F, Guglielmi A, Cescon M, Colasanti M, Di Sandro S, Gringeri E, Russolillo N, Ruzzenente A, Sposito C, Zanello M, Zimmitti G; Italian Association of HepatoBilioPancreatic Surgeons-AICEP., Italian Association of Hepato-Biliary-Pancreatic Surgeons-AICEP. Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study. Surgery 2021;170:383-9. [PMID: 33622570 DOI: 10.1016/j.surg.2021.01.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tsukamoto T, Nobori C, Nishiyama T, Kunimoto T, Kaizaki R, Inoue T, Nishiguchi Y. Stent-graft placement for delayed extrahepatic portal hemorrhage after surgical treatment for perihilar cholangiocarcinoma: A case report. Int J Surg Case Rep 2020;77:519-22. [PMID: 33395836 DOI: 10.1016/j.ijscr.2020.11.065] [Reference Citation Analysis]
31 Bari H, Wadhwani S, Dasari BVM. Role of artificial intelligence in hepatobiliary and pancreatic surgery. World J Gastrointest Surg 2021; 13(1): 7-18 [PMID: 33552391 DOI: 10.4240/wjgs.v13.i1.7] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Park HJ, Han DH, Choi GH, Choi JS. Surgical outcomes of perihilar cholangiocarcinoma based on the learning curve of a single surgeon at a tertiary academic hospital: A retrospective study. Ann Hepatobiliary Pancreat Surg 2021;25:54-61. [PMID: 33649255 DOI: 10.14701/ahbps.2021.25.1.54] [Reference Citation Analysis]
33 Matsukuma S, Tokumitsu Y, Shindo Y, Matsui H, Nagano H. Essential updates to the surgical treatment of biliary tract cancer. Ann Gastroenterol Surg 2019;3:378-89. [PMID: 31346577 DOI: 10.1002/ags3.12266] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
34 Teng F, Tang YY, Dai JL, Li Y, Chen ZY. The effect and safety of preoperative biliary drainage in patients with hilar cholangiocarcinoma: an updated meta-analysis. World J Surg Oncol 2020;18:174. [PMID: 32682432 DOI: 10.1186/s12957-020-01904-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Liang L, Li C, Jia HD, Diao YK, Xing H, Pawlik TM, Lau WY, Shen F, Huang DS, Zhang CW, Yang T. Prognostic factors of resectable perihilar cholangiocarcinoma: a systematic review and meta-analysis of high-quality studies. Ther Adv Gastrointest Endosc 2021;14:2631774521993065. [PMID: 33629062 DOI: 10.1177/2631774521993065] [Reference Citation Analysis]
36 Lu J, Li B, Li FY, Ye H, Xiong XZ, Cheng NS. Prognostic significance of mucinous component in hilar cholangiocarcinoma after curative-intent resection. J Surg Oncol 2019;120:1341-9. [PMID: 31612493 DOI: 10.1002/jso.25722] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
37 Lee TC, Morris MC, Patel SH, Shah SA. Expanding the Surgical Pool for Hepatic Resection to Treat Biliary and Primary Liver Tumors. Surg Oncol Clin N Am 2019;28:763-82. [PMID: 31472918 DOI: 10.1016/j.soc.2019.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]